# A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System

> **NCT03148522** · NA · UNKNOWN · sponsor: **Peking University** · enrollment: 120 (estimated)

## Conditions studied

- Diagnosis and Treatment of Depression

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Duloxetine
- **DRUG:** Mirtazapine

## Key facts

- **NCT ID:** NCT03148522
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03148522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03148522, "A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03148522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*